INMB $7.88 -5.4022%
2518.HK $57.00 5.0691%
EUZ.L $2.80 -9.6774%
AW9U.SI $0.26 -1.9231%
WELL $78.95 -0.259%
RNGR $11.32 1.2981%
VTIQW $0.00 0%
2331.HK $50.80 -0.3922%
SPRB $2.18 -3.5398%
PEMB.L $108.50 0%
AAME $2.23 1.1545%
NDRA $1.40 1.087%
OTLK $1.15 1.7699%
2197.HK $1.63 -4.6784%
MACQU $9.06 0%
APX.PA $110.25 -0.664%
EMWE.PA $16.84 0.3756%
1935.HK $1.12 0%
TPHC.PA $76.92 0.806%
PFTAU $10.28 -0.0972%
K71U.SI $0.87 -0.5747%
SLCA $12.17 -1.2976%
POAI $3.77 -2.2078%
C4S.PA $10.56 -0.4714%
PCGH.L $340.00 1.1905%
1431.HK $0.15 0%
CNP-PB $46.31 0%
1949.HK $0.23 0%
1075.HK $0.34 0%
OALC $21.21 -0.0518%
0JG5.L $4.20 -0.8274%
SXLK.L $77.83 -0.2611%
IEAA.L $4.72 -0.1797%
RFEU $61.84 -0.242%
PLYA $8.89 0.0563%
DRCT $2.92 -3.6304%
2638.HK $5.06 -1.1719%
SATL $2.22 -1.3333%
IIM $11.75 -0.4592%
EAP.CN $0.15 0%
REIT $24.13 -0.3461%
0848.HK $0.24 2.1277%
VLATW $0.00 0%
FOIL $27.13 0%
SEVN $9.09 0.3311%
LGAC $10.18 0%
PLUR $0.87 -2.0225%
SGLBW $0.01 0%
SC $41.60 0%
ALTA $44.16 0%
0QV6.L $3.88 0.3982%
8170.HK $0.38 0%
CNEW.L $15.52 -0.0193%
CHK $78.77 1.9544%
ROBO $52.56 -0.7553%
ZCAN $70.48 0%
T-PA $22.28 0.2056%
IGWD.L $7 353.00 0.0476%
ADC $66.24 -0.2635%
0GJS.L $34.80 0%
VFIN $3.65 0%
WATL.L $4 800.50 0.1669%
UAL $44.45 -1.4086%
1612.HK $0.45 0%
IPAC $57.30 -0.1742%
1587.HK $0.63 1.6129%
JEL.L $460.00 0%
0R1B.L $310.05 -0.0479%
OHPAW $0.00 0%
2121.HK $20.00 -2.6764%
FOSL $2.66 -7.3171%
LAW $5.66 -1.9931%
BNSO $2.87 -3.8121%
RPAD3.SA $7.49 16.4852%
0QDT.L $13.56 -5.17483%
SCRMU $10.35 0.2907%
HHR $15.03 0%
IHR.L $100.20 1.5198%
FHYS $22.25 -0.1884%
NR7.SI $0.06 0%
CINT $3.50 0%
LWDB.L $815.00 0%
NEWTL $24.40 0.0004%
1047.HK $0.44 0%
FBRT-PE $18.42 -2.2941%
8462.HK $0.05 0%
8096.HK $0.26 -3.7736%
ENCPW $0.07 -6.8%
DRAY $10.23 0%
JRI $11.32 -0.0265%
A31.SI $0.01 9.0909%
SOFIW $5.50 0%
IUG.L $12.25 -3.9216%
SSUS $32.84 -0.6053%
MLHYE.PA $149.00 0%
SDP.L $486.00 -0.4098%
CCV-UN $10.10 0%
0HCR.L $26.30 1.8985%
NCV $3.27 -1.2085%
CETX $9.57 -12.0404%
Eng
Логотип
Eng
Лого

Roivant Sciences Ltd. ROIVW

$2.00

+$0.02 (1.01%)
На 18:04, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    0.00000000

  • week52high

    2.06

  • week52low

    1.90

  • Revenue

    55286000

  • P/E TTM

    -980

  • Beta

    0.00000000

  • EPS

    -4.09200000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    07 мая 2023 г. в 07:33

Описание компании

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек

Insider Summary

Reporting Name Acquistion/Disposition Owned Transacted Transaction Date
Kumar Rakhi D 134340 1838 24 янв 2023 г.
Gline Matthew D 1109634 15594 24 янв 2023 г.
Venker Eric D 716372 13057 24 янв 2023 г.
Venker Eric D 729429 24037 05 янв 2023 г.
MOMTAZEE JAMES C A 59774 2447 03 янв 2023 г.
Oren Ilan A 60171 2010 03 янв 2023 г.
Venker Eric D 753466 95484 03 янв 2023 г.
Venker Eric D 848950 23761 30 дек 2022 г.
Venker Eric D 901647 16031 23 дек 2022 г.
Kumar Rakhi D 136178 1592 23 дек 2022 г.